Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013

5th Ocular Diseases & Drug Development

21 Mar 2013 - 22 Mar 2013 - San Francisco, CA, Hilton San Francisco Financial District

Bookmark and Share

To help promote the discovery of ocular disease and drug development, GTC is bringing together leading scientists, researchers, and experts to discuss and collaborate on the latest research and discovery, safety assessment, and drugs in development for combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, DME, uveitis and other eye diseases at the 5th Ocular Diseases and Drug Development Conference (March 21-22, 2013 in San Francisco, CA). The last annual conference was well attended with representation from key R&D folks from GSK, Pfizer, B&L, Allergan, Alcon and this year is showing promise to be even bigger and better.

Further information
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Wrapping up the Genome
Researchers successfully package complete yeast genome using purified components, yielding new insights into genome mechanisms.
Enlisting Insects to Protect Agriculture
New program aims for insect delivery of protective genes to modify mature plants within a single growing season.
New Mechanism of Plant RNA Degradation Identified
Researchers have identified a novel mechanism by which RNA is degraded.
New Model for Understanding Human Myeloma
Researchers develop mouse model where mice carry six human genes involved in human tumour growth.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Ethical Challenges of Genome Editing
A review of bioethics idnetifies two top challenges for genome editing.
Genetically Engineered Crops Are Safe
Study finds genetically engineered crop's risk to human health and the environment are no different than conventional crops.
Nimbolide Could Suppress Prostate Cancer Development
Oral administration of nimbolide over 12 weeks shows reduction of prostate tumour size and decrease in tumour metastasis.
Modified Yeast Shows Plant Response to Key Hormone
Researchers have developed a toolkit based on modified yeast to determine plant responses to auxin.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos